Related

SDGs and Paris Agreement force to change the current society to a sustainable, circular and wellness society, as well as the bio-based society across the globe. Based on these circumstances, the Japanese government has developed the “Japan Bioeconomy Strategy” since 2019 to achieve the world’s most advanced bioeconomy society in Japan by 2030. 


The strategy has three featuring points:

  • to promote each market segment in the nine fields with bio-manufacturing, primary production, and healthcare, to achieve 92T yen market size by 2030
  • to create outstanding bio-communities by the end of FY2021 and attract human resources and investment, and enable new products and services
  • to draw up guidelines for data linkage and usage by the end of FY2022, and establish R&D and market introduction platform. 

Industry, academia, and local governments pursue together the strategy and are able to receive various supports from the related Japanese government ministries as needed. The strategy also points out that even if each company or university individually struggles with biological technologies, the real industrialization is unable to be accomplished, and that bio-communities with strong/unique sciences and technologies are absolutely essential in Japan for effective open innovation.

Furthermore, international collaboration is essential to promote bioeconomy, and there is high potential for creating synergies among states sharing fundamental values. Currently, six bio-communities, two global bio-communities and four local bio-communities with unique sciences and technologies, were certified by the Japanese Government Cabinet Office. Companies based in the EU are also invited to get involved and contribute.

Nine market-segments

  1. High functional biomaterials (lightweight properties, durability, safety)
  2.  Bioplastics (alternative general-purpose plastics)
  3. Sustainable primary industry system
  4. Organic (Biological) treatment of wastes and effluent
  5. Healthcare field (lifestyle improvement, functional foods, digital health)
  6. Biologics (e.g. antibodies, regenerative medicines, cell therapy, gene therapy, gene editing)
  7. Biological production system (production applying biological functions)
  8. Analysis, measurement, and experiment systems for biological products
  9. Large timber architecture / Smart forestry

 

EU-Japan Centre's News

More
The EU-Japan Centre is currently calling for expert report proposals for its quarterly ‘Japanese…
The EU-Japan Centre is currently calling for expert report proposals for a new periodic monitoring…
The Minerva Policy Reports deliver comprehensive research on the dynamic political, economic, and…
JTPP Helpdesk's Weekly Digest of Public Sector Tenders is a selection of tenders found on the Japan…

Events

More
Japan
01/08/2024 - 31/03/2025
  The organization of the Vulcanus Programme is pending reception of a grant by the EU-Japan Centre for Industrial Cooperation for the Japanese fiscal year 2024-2025: Please note that this call is…
Japan
07/10/2024 - 11/10/2024
Are you running a business that operates in the Pharma, Biotechnologies, or Life Sciences sectors? Would you like to present your technologies and products to potential partners and clients from…
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
Subscribe